experimental drug reported effects alzheimers disease ageing mouse models accelerated approach lead development drug screen candidate molecules antiaging effects instead targeting amyloid plaques contrary approaches developing drugs alzheimers disease target plaque deposits drug also reported address biological aging factors preventing leakage blood microvessels mice development follows chemical pharmacological way contrary biological ways exploit eg use derivative enhanced neurogenic activity human neural precursor cells enhances use free fatty acids energy production shifting metabolic profile fatty acids toward production ketone bodies alternative source energy brain glucose levels target molecule protein called atp synthase found drug article relating nervous system stub help wikipedia expanding